BEAT - BioTelemetry, Inc.
| Previous Close | 46.56 |
| Open | 46.61 |
| Bid | 45.27 x 1000 |
| Ask | 45.34 x 2200 |
| Day's Range | 44.57 - 46.78 |
| 52 Week Range | 44.57 - 80.92 |
| Volume | 702,165 |
| Avg. Volume | 433,409 |
| Market Cap | 1.53B |
| Beta (3Y Monthly) | 1.63 |
| PE Ratio (TTM) | 33.61 |
| EPS (TTM) | 1.35 |
| Earnings Date | Jul 30, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 80.80 |
- GlobeNewswire•2 days ago
BioTelemetry, Inc. to Release Second Quarter 2019 Earnings Results on July 30, 2019
MALVERN, Pa., July 19, 2019 -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2019 earnings on Tuesday, July 30 at 4:00 PM Eastern Time. The BioTelemetry.
- Zacks•3 days ago
BioTelemetry (BEAT) to Report Q2 Earnings: What's in Store?
BioTelemetry's (BEAT) strong second-quarter 2019 expectations are indicative of solid results.
- Zacks•4 days ago
Analysts Estimate BioTelemetry (BEAT) to Report a Decline in Earnings: What to Look Out for
BioTelemetry (BEAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.•5 days ago
Does BioTelemetry, Inc.'s (NASDAQ:BEAT) CEO Salary Compare Well With Others?
In 2010 Joe Capper was appointed CEO of BioTelemetry, Inc. (NASDAQ:BEAT). This analysis aims first to contrast CEO...
- Investor's Business Daily•11 days ago
Why You Should Keep An Eye On These Leading Health Care Stocks
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
- Simply Wall St.•last month
With A Return On Equity Of 15%, Has BioTelemetry, Inc.'s (NASDAQ:BEAT) Management Done Well?
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
- GlobeNewswire•2 months ago
Itamar Medical and BioTel Heart, a Division of BioTelemetry, Expand Collaboration to Offer Itamar’s Total Sleep Solution™ to BioTel Heart Cardiology Customers
Itamar Medical Ltd. (NASDAQ and TASE:ITMR), a company that develops, manufacturers and markets non-invasive diagnostic devices for sleep apnea with a focus on the cardiology market, and BioTel Heart, a division of BioTelemetry, Inc. (BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced an expanded collaboration to make Itamar Medical’s Total Sleep Solution available to select BioTel Heart cardiology customers in the United States. The collaboration is designed to respond to the growing demand for home sleep apnea testing among cardiologists, who recognize effective sleep apnea management as a critical strategy for improving health in patients with cardiac disease.
- Zacks•2 months ago
BioTelemetry (BEAT) Outpaces Stock Market Gains: What You Should Know
BioTelemetry (BEAT) closed the most recent trading day at $47.69, moving +1.6% from the previous trading session.
- Simply Wall St.•2 months ago
Does BioTelemetry, Inc. (NASDAQ:BEAT) Have A High Beta?
If you own shares in BioTelemetry, Inc. (NASDAQ:BEAT) then it's worth thinking about how it contributes to the...
- GlobeNewswire•2 months ago
BioTelemetry President and CEO Joseph H. Capper Named Healthcare CEO of the Year at 26th Annual PACT Enterprise Awards
BioTelemetry (BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced that Joseph H. Capper, President and CEO, has been awarded the 2019 Healthcare CEO of the Year Award by the Philadelphia Alliance for Capital and Technologies, or PACT. The Healthcare CEO of the Year Award recognizes leaders for their management accomplishments and philosophy, including the communication of a vision and goals as achieved by the company. “Each day we work with our customers and business partners to make a difference in the lives of our patients and communities,” said Joseph H. Capper, President and CEO of BioTelemetry.
- Insider Monkey•3 months ago
Here’s What Hedge Funds Think About BioTelemetry, Inc. (BEAT)
Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks may provide us with significant returns as well. Many hedge funds, like Paul Singer’s Elliott Management, are pretty secretive, but we can still get some insights by analyzing […]
- Thomson Reuters StreetEvents•3 months ago
Edited Transcript of BEAT earnings conference call or presentation 25-Apr-19 9:00pm GMT
Q1 2019 BioTelemetry Inc Earnings Call
Motley Fool•3 months agoBioTelemetry Inc (BEAT) Q1 2019 Earnings Call Transcript
BEAT earnings call for the period ending March 31, 2019.
- Benzinga•3 months ago
The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 25) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN ...
- Associated Press•3 months ago
BioTelemetry: 1Q Earnings Snapshot
On a per-share basis, the Malvern, Pennsylvania-based company said it had profit of 32 cents. Earnings, adjusted for one-time gains and costs, were 42 cents per share. The results met Wall Street expectations. ...
- GlobeNewswire•3 months ago
BioTelemetry, Inc. Reports First Quarter 2019 Financial Results
Achieves Record Quarterly Revenue Raises Full Year 2019 Guidance MALVERN, Pa., April 25, 2019 -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology.
- Simply Wall St.•3 months ago
Should You Investigate BioTelemetry, Inc. (NASDAQ:BEAT) At US$58.57?
BioTelemetry, Inc. (NASDAQ:BEAT), which is in the healthcare business, and is based in United States, received a lot of attention from a substantial price movement on the NASDAQGS ove...
- Zacks•3 months ago
BioTelemetry (BEAT) to Report Q1 Earnings: What's in Store?
Products like MCT and Ware Holter are likely to aid BioTelemetry (BEAT) in Q1.
- Zacks•3 months ago
Top Stock Picks for the Week of Apr 22, 2019
Tracey Ryniec and Kevin Cook look at two highly rated stocks.
- GlobeNewswire•3 months ago
BioTelemetry, Inc. to Release First Quarter 2019 Earnings Results on April 25, 2019
MALVERN, Pa., April 18, 2019 -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its first quarter 2019 earnings on Thursday, April 25 at 4:00 PM Eastern Time. The BioTelemetry.
- Zacks•3 months ago
BioTelemetry (BEAT) Earnings Expected to Grow: Should You Buy?
BioTelemetry (BEAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks•3 months ago
Teladoc's Partnership to Form Pediatric Telehealth Platform
Teladoc (TDOC) teams up with Cincinnati Children's Hospital Medical Center to launch consumer pediatric telehealth platform.
